<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1193">
 <bold>Introduction:</bold> Vasopressor therapy is required to sustain life and maintain perfusion in the face of life-threatening hypotension occurring with severe sepsis and septic shock, even when hypovolemia has not yet been resolved. [1] We hypothesized that a dose of norepinephrine administered in the first 24Â hours correlates with the outcome of treatment in patients with severe sepsis and septic shock.
</p>
